Cargando…

Antibody Profiles According to Mild or Severe SARS-CoV-2 Infection, Atlanta, Georgia, USA, 2020

Among patients with coronavirus disease (COVID-19), IgM levels increased early after symptom onset for those with mild and severe disease, but IgG levels increased early only in those with severe disease. A similar pattern was observed in a separate serosurveillance cohort. Mild COVID-19 should be i...

Descripción completa

Detalles Bibliográficos
Autores principales: Hu, William T., Howell, J. Christina, Ozturk, Tugba, Benameur, Karima, Bassit, Leda C., Ramonell, Richard, Cashman, Kevin S., Pirmohammed, Shama, Roback, John D., Marconi, Vincent C., Yang, Irene, Mac, Valerie V., Smith, Daniel, Sanz, Ignacio, Wharton, Whitney, Lee, F. Eun-Hyung, Schinazi, Raymond F.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Centers for Disease Control and Prevention 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7706962/
https://www.ncbi.nlm.nih.gov/pubmed/32857691
http://dx.doi.org/10.3201/eid2612.203334
_version_ 1783617260051496960
author Hu, William T.
Howell, J. Christina
Ozturk, Tugba
Benameur, Karima
Bassit, Leda C.
Ramonell, Richard
Cashman, Kevin S.
Pirmohammed, Shama
Roback, John D.
Marconi, Vincent C.
Yang, Irene
Mac, Valerie V.
Smith, Daniel
Sanz, Ignacio
Wharton, Whitney
Lee, F. Eun-Hyung
Schinazi, Raymond F.
author_facet Hu, William T.
Howell, J. Christina
Ozturk, Tugba
Benameur, Karima
Bassit, Leda C.
Ramonell, Richard
Cashman, Kevin S.
Pirmohammed, Shama
Roback, John D.
Marconi, Vincent C.
Yang, Irene
Mac, Valerie V.
Smith, Daniel
Sanz, Ignacio
Wharton, Whitney
Lee, F. Eun-Hyung
Schinazi, Raymond F.
author_sort Hu, William T.
collection PubMed
description Among patients with coronavirus disease (COVID-19), IgM levels increased early after symptom onset for those with mild and severe disease, but IgG levels increased early only in those with severe disease. A similar pattern was observed in a separate serosurveillance cohort. Mild COVID-19 should be investigated separately from severe COVID-19.
format Online
Article
Text
id pubmed-7706962
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Centers for Disease Control and Prevention
record_format MEDLINE/PubMed
spelling pubmed-77069622020-12-08 Antibody Profiles According to Mild or Severe SARS-CoV-2 Infection, Atlanta, Georgia, USA, 2020 Hu, William T. Howell, J. Christina Ozturk, Tugba Benameur, Karima Bassit, Leda C. Ramonell, Richard Cashman, Kevin S. Pirmohammed, Shama Roback, John D. Marconi, Vincent C. Yang, Irene Mac, Valerie V. Smith, Daniel Sanz, Ignacio Wharton, Whitney Lee, F. Eun-Hyung Schinazi, Raymond F. Emerg Infect Dis Dispatch Among patients with coronavirus disease (COVID-19), IgM levels increased early after symptom onset for those with mild and severe disease, but IgG levels increased early only in those with severe disease. A similar pattern was observed in a separate serosurveillance cohort. Mild COVID-19 should be investigated separately from severe COVID-19. Centers for Disease Control and Prevention 2020-12 /pmc/articles/PMC7706962/ /pubmed/32857691 http://dx.doi.org/10.3201/eid2612.203334 Text en https://creativecommons.org/licenses/by/4.0/This is a publication of the U.S. Government. This publication is in the public domain and is therefore without copyright. All text from this work may be reprinted freely. Use of these materials should be properly cited.
spellingShingle Dispatch
Hu, William T.
Howell, J. Christina
Ozturk, Tugba
Benameur, Karima
Bassit, Leda C.
Ramonell, Richard
Cashman, Kevin S.
Pirmohammed, Shama
Roback, John D.
Marconi, Vincent C.
Yang, Irene
Mac, Valerie V.
Smith, Daniel
Sanz, Ignacio
Wharton, Whitney
Lee, F. Eun-Hyung
Schinazi, Raymond F.
Antibody Profiles According to Mild or Severe SARS-CoV-2 Infection, Atlanta, Georgia, USA, 2020
title Antibody Profiles According to Mild or Severe SARS-CoV-2 Infection, Atlanta, Georgia, USA, 2020
title_full Antibody Profiles According to Mild or Severe SARS-CoV-2 Infection, Atlanta, Georgia, USA, 2020
title_fullStr Antibody Profiles According to Mild or Severe SARS-CoV-2 Infection, Atlanta, Georgia, USA, 2020
title_full_unstemmed Antibody Profiles According to Mild or Severe SARS-CoV-2 Infection, Atlanta, Georgia, USA, 2020
title_short Antibody Profiles According to Mild or Severe SARS-CoV-2 Infection, Atlanta, Georgia, USA, 2020
title_sort antibody profiles according to mild or severe sars-cov-2 infection, atlanta, georgia, usa, 2020
topic Dispatch
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7706962/
https://www.ncbi.nlm.nih.gov/pubmed/32857691
http://dx.doi.org/10.3201/eid2612.203334
work_keys_str_mv AT huwilliamt antibodyprofilesaccordingtomildorseveresarscov2infectionatlantageorgiausa2020
AT howelljchristina antibodyprofilesaccordingtomildorseveresarscov2infectionatlantageorgiausa2020
AT ozturktugba antibodyprofilesaccordingtomildorseveresarscov2infectionatlantageorgiausa2020
AT benameurkarima antibodyprofilesaccordingtomildorseveresarscov2infectionatlantageorgiausa2020
AT bassitledac antibodyprofilesaccordingtomildorseveresarscov2infectionatlantageorgiausa2020
AT ramonellrichard antibodyprofilesaccordingtomildorseveresarscov2infectionatlantageorgiausa2020
AT cashmankevins antibodyprofilesaccordingtomildorseveresarscov2infectionatlantageorgiausa2020
AT pirmohammedshama antibodyprofilesaccordingtomildorseveresarscov2infectionatlantageorgiausa2020
AT robackjohnd antibodyprofilesaccordingtomildorseveresarscov2infectionatlantageorgiausa2020
AT marconivincentc antibodyprofilesaccordingtomildorseveresarscov2infectionatlantageorgiausa2020
AT yangirene antibodyprofilesaccordingtomildorseveresarscov2infectionatlantageorgiausa2020
AT macvaleriev antibodyprofilesaccordingtomildorseveresarscov2infectionatlantageorgiausa2020
AT smithdaniel antibodyprofilesaccordingtomildorseveresarscov2infectionatlantageorgiausa2020
AT sanzignacio antibodyprofilesaccordingtomildorseveresarscov2infectionatlantageorgiausa2020
AT whartonwhitney antibodyprofilesaccordingtomildorseveresarscov2infectionatlantageorgiausa2020
AT leefeunhyung antibodyprofilesaccordingtomildorseveresarscov2infectionatlantageorgiausa2020
AT schinaziraymondf antibodyprofilesaccordingtomildorseveresarscov2infectionatlantageorgiausa2020